BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160704
DTEND;VALUE=DATE:20160901
DTSTAMP:20260902T222337
CREATED:20160704T183407Z
LAST-MODIFIED:20160705T124600Z
UID:16304-1467590400-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Research Associate in pancreatic cancer pathogenesis (Chapel Hill\, NC\, USA)
DESCRIPTION:Lineberger Comprehensive Cancer Center Research Laboratory aims to understand the pathogenesis and pharmacogenomics of pancreatic cancer in order to accelerate its treatment. Using a combination of molecular and genomic data\, and human in mouse models\, we have identified four core subtypes in pancreatic cancer with important biologic and clinical implications. We are seeking a postdoctoral associate in cancer genomics and personalized medicine who will be responsible for computational method development\, data analysis\, and experimental design. The qualified candidate will integrate information from a combination of sources\, including high throughput screens\, proteomic\, and next-gen sequencing data in order to generate and validate hypotheses of therapeutic relevance to pancreatic cancer. The ideal candidate will have excellent qualifications in a quantitative/computational field with a strong interest in learning cancer biology and/or wet bench techniques. Candidates from a largely wet bench background with a Ph.D. may be considered if the quantitative/computational background is excellent. \nTo be successful\, the candidate must have experience in and interested in developing several of the following skill-sets: thorough knowledge of cancer biology\, epigenetics\, proteomics\, and transcriptomics; familiarity with next-generation sequencing data analysis tools; experience working in Linux environments\, including batch job management on shared computing resources; familiarity with a variety of supervised and unsupervised classification techniques; proficiency in one or more statistical or scripting languages\, preferably R or MATLAB; knowledge of survival-based statistical analysis\, e.g. Cox regression and Kaplan-Meier analysis; working knowledge of best-practices for machine learning to avoid over fitting; familiarity with common experimental techniques in molecular biology; ability to communicate scientific material and collaborate well with computational and non-computational partners; excellent oral and written communication skills and the ability to perform both self-directed and guided research; outstanding personal initiative and the ability to work effectively as part of a team; willingness to assist in the mentorship and training of pre-doctoral researchersPh.D. in a quantitative/computational field or a Ph.D. with an equivalent certificate in a quantitative/computational field is required; have experience in handling large datasets and have applied/developed computational algorithms in the context of molecular biology; have a thorough understanding of common statistical tests and distributions; be able to collaborate with experimental team members for validation of computational results; be comfortable maintaining datasets\, as well as displaying and interpreting processed data for publication; work alongside domain experts in the optimization and development of experimental measurement platforms and protocols.
URL:https://ces.b2sg.org/event/postdoctoral-research-associate-in-pancreatic-cancer-pathogenesis/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160705
DTEND;VALUE=DATE:20160716
DTSTAMP:20260902T222337
CREATED:20160705T075627Z
LAST-MODIFIED:20160705T124131Z
UID:16313-1467676800-1468627199@ces.b2sg.org
SUMMARY:Post-Doctoral Research Fellow in Epigenetics (Mainz\, Germany)
DESCRIPTION:Institute of Molecular Biology (IMB)\, Mainz\, Germany\nDescription\nThe Institute of Molecular Biology (IMB) funded by the Boehringer Ingelheim Foundation is recruiting a Post-Doctoral Research Fellow in Epigenetics (#VTPD11) \nThe Institute of Molecular Biology (IMB) is a Centre of Excellence for Life Sciences\, funded by the Boehringer Ingelheim Foundation\, and located in Mainz\, Germany. Applications are invited for a postdoctoral researcher position in the laboratory of Dr. Vijay Tiwari.The successful applicant will contribute to internationally competitive research on epigenetic regulation of cell-fate specification during development. The group employs high-throughput epigenomics assays in combination with stem cell biology and neurobiology and cutting-edge epigenetics and molecular biology tools. The resulting datasets are analysed using computational and systems biology approaches to generate a comprehensive model of epigenetic regulation of gene expression during embryonic development. \nYou will \n\nStudy epigenetic mechanisms that regulate cell-type specification during neuronal development\nUtilize mouse embryonic stem cell differentiation and mouse as a model system\nObtain training in epigenetics\, gene regulation\, developmental biology and computational biology\nHave access to all IMB Core Facilities\nCollaborate with internal and external partners\nWork in close cooperation with a team of experimental and computational researchers to facilitate novel discoveries\n\nRequired Qualifications\n\nPhD in molecular biology\, neurobiology\, epigenetics\, biochemistry or developmental biology\, preferentially with a background in gene regulation\nStrong experience in at least one of the following areas: embryonic development\, stem cell biology\, neurobiology\, epigenetics\nAt least one first author paper in an international peer reviewed journal\nGood written and spoken English\nInterest in working in a multidisciplinary team\nCompetitiveness at the international level and willing to collaborate with internal and external collaborators as well as supporting other group members\n\nWe offer \n\nThe possibility to work on cutting-edge projects using state-of-the-art technology\nA stimulating\, diverse and international research environment\nAdvanced training opportunities\nCareer development\nCompetitive salary\nHighly motivated research team\n\nApplication details\nTo apply\, please email a cover letter\, your CV (in English)\, contact address of at least two professional referees and certificates of your degrees quoting Ref. No. #VTPD11 to personnel@imb-mainz.de. Informal inquires should be addressed to Dr. Vijay Tiwari (v.tiwari@imb-mainz.de). IMB is an equal opportunity employer. \nStarting date: 1st Aug 2016 or later; duration: Initially 2 years with option of further extension.\nDeadline for applications: 15th July 2016
URL:https://ces.b2sg.org/event/post-doctoral-research-fellow-in-epigenetics/
LOCATION:IMB Mainz\, Ackermannweg 4\, Mainz\, 55128 \, Germany
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/IMB_Mainz-1.png
ORGANIZER;CN="Dr.%20Vijay%20Tiwari":MAILTO:personnel@imb-mainz.de
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160705
DTEND;VALUE=DATE:20161101
DTSTAMP:20260902T222337
CREATED:20160705T124949Z
LAST-MODIFIED:20160706T133740Z
UID:16333-1467676800-1477958399@ces.b2sg.org
SUMMARY:Postdoc in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A postdoctoral position is immediately available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks (ULB – Université Libre de Bruxelles/Free University of Brussels\, Belgium). \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS (http://epics.ulb.be/) and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, encompassing fundamental\, translational and clinical research and providing an excellent scientific environment to conduct high profile research.\nWe are looking for a highly motivated candidate with extensive experience in molecular and cell biology. Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related disciplines (or have recently submitted their thesis with their defence scheduled) and have published (or about to publish) in a peer reviewed journal. Experience in epigenetics/epigenomics would be an asset. \nThe position is funded for 3 years. Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date. \nInformal enquiries\, a CV\, a motivation letter and names of two referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab\nLab NGS platform: http://epics.ulb.be/ \nSelected publications:\n– Delatte et al. Science 2016\n– Delatte et al. Science Rep. 2015\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature. 2010\n– Epsztejn-Litman Nat Struct Mol Biol. 2008\n– Villa et al. Cancer Cell. 2007\n– Brenner & Fuks Dev Cell. 2007\n– Viré et al. Nature 2006\n– Brenner et al. EMBO J. 2005
URL:https://ces.b2sg.org/event/postdoc-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160706
DTEND;VALUE=DATE:20161101
DTSTAMP:20260902T222337
CREATED:20160706T131829Z
LAST-MODIFIED:20160706T133508Z
UID:16337-1467763200-1477958399@ces.b2sg.org
SUMMARY:PhD in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A PhD position is available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks at the Université libre de Bruxelles (ULB)\, Brussels\, Belgium. \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS\, and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, providing an excellent scientific environment to conduct high profile research encompassing fundamental\, translational and clinical research. \nCandidates with a good first degree (BSc or MSc) in Biology\, Genetics\, Biochemistry or a related life science subject are all invited to apply. Preferred qualifications include excellent grades\, research talent (as proven by the master thesis) and personal ambition. Candidates are expected to have good academic writing and presentation skills. Screening of applications begins immediately and continues until an outstanding candidate is selected. \nThe position is funded for 3 years\, in the first instance. Screening of applications begins immediately and continues until an outstanding candidate is selected. The starting date is September 30\, 2016 at the latest. \nInformal enquiries\, a CV (including grades and class ranking)\, a motivation letter and names of three referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab \nLab NGS platform EPICS: http://epics.ulb.be/ \nUniversity website: https://www.ulb.ac.be/ulb/presentation/uk.html \nSelected publications:\n– Delatte et al. Science 2016\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature 2010\n– Villa et al. Cancer Cell 2007\n– Viré et al. Nature 2006
URL:https://ces.b2sg.org/event/phd-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160710
DTEND;VALUE=DATE:20160716
DTSTAMP:20260902T222337
CREATED:20160426T124955Z
LAST-MODIFIED:20160625T073423Z
UID:15318-1468108800-1468627199@ces.b2sg.org
SUMMARY:FASEB: Dynamic DNA Structures in Biology
DESCRIPTION:For decades after its discovery\, genomic DNA was believed to exist only as a right-handed\, double helix known as B-DNA.  Its sole functions were to serve as a template for RNA synthesis or as a template for the production of identical duplexes during chromosome replication.  These core beliefs were shaken by the discovery that DNA is covalently modified and packaged into chromatin\, and that the molecule can form an enormous variety of non-B alternative structures\, including cruciforms\, a left-handed helix\, three- and four-stranded helices\, and slip-strand configurations.  Transient denaturation of the duplex during all major DNA transactions (replication\, transcription\, repair and recombination) requires chromatin modifications and promotes dynamic transitions to non-B DNA structures.  Furthermore\, repetitive DNA sequences\, which are highly over-represented in genomic DNA\, are particularly prone to structural transitions.  Studies conducted in many labs worldwide have confirmed that structural transitions are not only central to normal functions of the genome\, but also are responsible for occasional malfunctioning that leads to a disease state.  The most striking example is expansion of structure-prone DNA repeats\, which is responsible for more than thirty hereditary neurological and developmental diseases. \n\n\n\n\n\n\n\n\n\nThis SRC is the fourth meeting on Dynamic DNA Structures in Biology\, a highly interactive meeting that brings together a diverse\, international community of researchers who maintain a “DNA-centric” view of basic biological processes.  Attendees will include those interested in disease-causing repeat expansions\, chromatin dynamics\, chromosome fragility related to transcription and replication\, and the biological roles of unusual\, non-B DNA structures.  Morning and evening scientific sessions will feature established and new investigators\, and ample time for discussion will be incorporated into the program.  In addition\, short talks chosen from submitted abstracts will be included in session\, with preference given to trainees.  Afternoon poster sessions will further foster the exchange of ideas and facilitate the establishment of new collaborations.  It is anticipated that funds will be available to support the attendance of young investigators and trainees.
URL:https://ces.b2sg.org/event/faseb-dynamic-dna-structures-in-biology/
LOCATION:Horowitz Performing Arts Hall and Nita Choukas Theater\,  Long Walk 10\,  Saxtons River\, VT\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/FASEB.png
END:VEVENT
END:VCALENDAR